查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712502

日本患者參與解決方案市場 - 2025-2033

Japan Patient Engagement Solutions Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年，日本患者參與解決方案市場規模達到 27314.1 億美元，預計到 2033 年將達到 161672.6 億美元，在 2025-2033 年預測期內的複合年成長率為 19.4%。

患者參與解決方案是讓患者參與醫療保健過程的數位工具，可改善溝通，促進健康行為並實現即時存取醫療記錄。這些工具可以幫助人們做出明智的健康決定，支持慢性病管理，降低醫院再入院率，並提高照護品質。隨著基於價值的照護模式和數位化健康轉型的出現，這些工具擴大融入醫療保健系統。隨著對預防性護理和以患者為中心的方法的日益重視，患者參與解決方案對於改善健康結果和創造協作的醫療環境至關重要。

市場動態：

駕駛員和約束裝置

基於價值的護理需求不斷成長

由於國家轉向基於價值的護理模式，患者參與解決方案市場正在成長，該模式優先考慮更好的健康結果、患者滿意度和成本效率。醫療保健提供者正在採用數位工具來增強患者和提供者之間的溝通和協作。這些解決方案，例如行動應用程式、遠端監控系統和線上門戶，有助於追蹤患者進度、鼓勵堅持治療並減少醫院再入院，對於實現這些目標至關重要。

此外，日本政府和醫療保健提供者正在實施數據驅動的方法、綜合護理系統和基於結果的報銷結構，以提高服務品質和永續性。預計這一趨勢將推動數位健康、慢性病管理和個人化醫療領域的創新，使基於價值的照護成為日本未來醫療保健策略的重要支柱。

資料隱私和安全問題

患者參與技術越來越受歡迎，但對資料隱私和安全的擔憂仍然是一個重大挑戰。這些解決方案涉及敏感患者資訊的收集、儲存和交換，這些資訊很容易受到網路攻擊和洩漏。遵守 HIPAA 和 GDPR 等監管框架至關重要，否則可能會導致法律後果並失去患者的信任。在網路安全措施上投入大量資金可能會增加營運成本並減緩新技術的實施。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按組件截取片段
  • 以交付方式分類的程式碼片段
  • 按應用程式截取的程式碼片段
  • 按治療領域分類
  • 最終用戶的程式碼片段

第3章：動態

  • 影響因素
    • 驅動程式
      • 基於價值的護理需求不斷成長
      • 數位化醫療和遠距醫療服務日益普及
    • 限制
      • 資料隱私和安全問題
      • 老年人口的數位素養有限
    • 機會
      • 人工智慧和機器學習在互動平台中的整合
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：按組件

  • 桌面設備
  • 硬體
  • 服務

第6章：依交付方式

  • 基於網路
  • 基於雲端
  • 本地部署

第7章：按應用

  • 健康管理
  • 家庭健康管理
  • 社會與行為管理
  • 財務健康管理

第 8 章：按治療領域

  • 醫院和診所
  • 健康
  • 女性健康
  • 心理健康
  • 其他

第 9 章：按最終用戶

  • 提供者
  • 付款人
  • 患者
  • 其他

第10章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • CureApp
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Oracle Corporation
  • NTT Data
  • Fujitsu Limited
  • M3

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: HCIT9495

The Japan patient engagement solutions market reached US$ 2731.41 billion in 2024 and is expected to reach US$ 16,167.26 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.

Patient engagement solutions are digital tools that involve patients in their healthcare journey, improving communication, promoting healthy behaviors, and enabling real-time access to medical records. These tools enable informed decisions about health, support chronic disease management, reduce hospital readmission rates, and enhance care quality. As value-based care models and digital health transformation emerge, these tools are increasingly integrated into healthcare systems. With a growing emphasis on preventive care and patient-centered approaches, patient engagement solutions are crucial for improving health outcomes and fostering a collaborative healthcare environment.

Market Dynamics: Drivers & Restraints

Rising Demand for Value-Based Care

The patient engagement solutions market is growing due to the country's shift towards value-based care models, which prioritize better health outcomes, patient satisfaction, and cost efficiency. Healthcare providers are adopting digital tools to enhance communication and collaboration between patients and providers. These solutions, such as mobile apps, remote monitoring systems, and online portals, help track patient progress, encourage treatment adherence, and reduce hospital readmissions, making them critical for achieving these goals.

Moreover, the Japan government and healthcare providers are implementing data-driven approaches, integrated care systems, and outcome-based reimbursement structures to improve service quality and sustainability. This trend is expected to drive innovation in digital health, chronic disease management, and personalized medicine, positioning value-based care as a key pillar of Japan's future healthcare strategy.

Data Privacy and Security Concerns

Patient engagement technologies are gaining popularity, but concerns about data privacy and security remain a significant challenge. These solutions involve the collection, storage, and exchange of sensitive patient information, which is vulnerable to cyberattacks and breaches. Compliance with regulatory frameworks like HIPAA and GDPR is crucial, and failure to do so can lead to legal consequences and loss of patient trust. Investing heavily in cybersecurity measures can increase operational costs and slow new technology implementation.

Segment Analysis

The Japan patient engagement solutions market is segmented based on component, delivery mode, application, therapeutic area, and End-User.

Component:

The software from the component segment is expected to dominate the Japan patient engagement solutions market with the highest market share

Software is a set of instructions, programs, or data used to operate computers and perform specific tasks. It is intangible and tells hardware what to do, ranging from operating systems like Windows or macOS to apps like Microsoft Word, mobile apps, games, and specialized programs for businesses and healthcare. Software is the brain behind the machine, enabling tasks like calculating, displaying information, managing files, and communicating over the internet.

The patient engagement solutions market is gaining popularity due to the growing use of digital health tools, the burden of chronic diseases, and government initiatives promoting eHealth and digital health transformation. Software platforms can efficiently provide continuous patient monitoring and communication, while the integration of artificial intelligence and data analytics enhances personalization and clinical decision-making. As a result, software is becoming an indispensable component of modern patient engagement strategies.

For instance, in January 2023, Fujitsu and Sapporo Medical University launched a joint project to enable data portability for patients' healthcare data, including electronic health records (EHRs) and personal health records (PHRs). The project will involve Fujitsu developing a mobile app for iPhone users to view healthcare data and a cloud-based platform for managing patients' health data. This marks the first initiative in Japan to link electronic medical records with Apple's Health app.

Competitive Landscape

The major country players in the Japan patient engagement solutions market include CureApp, Oracle Corporation, NTT Data, Fujitsu Limited, and M3, among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan patient engagement solutions market report delivers a detailed analysis with 30 key tables, more than 35 visually impactful figures and 115 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Component
  • 2.4. Snippet by Delivery Mode
  • 2.5. Snippet by Application
  • 2.6. Snippet by Therapeutic Area
  • 2.7. Snippet by End-User

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Demand for Value-Based Care
      • 3.1.1.2. Growing Digital Health Adoption and Telemedicine Services
    • 3.1.2. Restraints
      • 3.1.2.1. Data Privacy and Security Concerns
      • 3.1.2.2. Limited Digital Literacy Among the Elderly Population
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of AI and Machine Learning in Engagement Platforms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Porter's Five Force Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders

5. By Component

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 5.1.2. Market Attractiveness Index, By Component
  • 5.2. Table-top Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Hardware
  • 5.4. Services

6. By Delivery Mode

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 6.1.2. Market Attractiveness Index, By Delivery Mode
  • 6.2. Web-based*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cloud-based
  • 6.4. On-premise

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Health Management*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Home Health Management
  • 7.4. Social and Behavioral Management
  • 7.5. Financial Health Management

8. By Therapeutic Area

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 8.1.2. Market Attractiveness Index, By Therapeutic Area
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Fitness
  • 8.4. Women's Health
  • 8.5. Mental Health
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Payers
  • 9.4. Patients
  • 9.5. Others

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. CureApp*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Oracle Corporation
  • 11.3. NTT Data
  • 11.4. Fujitsu Limited
  • 11.5. M3

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us